J. Samuel

发表

Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells.

Praveen Elamanchili, M. Diwan, Min Cao, 2004, Vaccine.

Micelles self-assembled from poly(ethylene oxide)-block-poly(N-hexyl stearate L-aspartamide) by a solvent evaporation method: effect on the solubilization and haemolytic activity of amphotericin B.

G. Kwon, A. Lavasanifar, J. Samuel, 2001, Journal of controlled release : official journal of the Controlled Release Society.

Micelles of poly(ethylene oxide)-block-poly(N-alkyl stearate L-aspartamide): synthetic analogues of lipoproteins for drug delivery.

G. Kwon, A. Lavasanifar, J. Samuel, 2000, Journal of biomedical materials research.

Development of active specific immunotherapeutic agents based on cancer-associated mucins.

J. Samuel, B. Longenecker, 1995, Pharmaceutical biotechnology.

A novel marker for basal (stem) cells of mammalian stratified squamous epithelia and squamous cell carcinomas.

D. Haines, B. Longenecker, B. M. Longenecker, 1989, Cancer research.

Micelles of poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin.

R. Lai, A. Lavasanifar, A. Haddadi, 2008, Journal of biomedical materials research. Part A.

Nanotechnology for Cancer Vaccine Delivery

A. Alshamsan, S. Hamdy, J. Samuel, 2009 .

Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity.

A. Alshamsan, A. Lavasanifar, S. Hamdy, 2008, Vaccine.

Isolation and Characterization of a Novel Cardiac Stimulatory and Haemolytic Protein from the Sea Anemone Urticina piscivora (Sebens and Laakso)

L. Wiebe, R. George, J. Samuel, 1995 .

Block Copolymer Micelles for the Encapsulation and Delivery of Amphotericin B

G. Kwon, A. Lavasanifar, J. Samuel, 2002, Pharmaceutical Research.

Development of a poly(d,l-lactic-co-glycolic acid) nanoparticle formulation of STAT3 inhibitor JSI-124: implication for cancer immunotherapy.

R. Lai, A. Lavasanifar, A. Mahmud, 2010, Molecular pharmaceutics.

Toxic effects of the novel protein UpI from the sea anemone Urticina piscivora.

J. Young, L. Wiebe, J. Samuel, 1995, Pharmacological research.

Immunogenicity of synthetic peptides related to the core peptide sequence encoded by the human MUC1 mucin gene: Effect of immunization on the growth of murine mammary adenocarcinoma cells transfected with the human MUC1 gene

J. Taylor‐Papadimitriou, M. Reddish, E. Lalani, 2005, Cancer Immunology, Immunotherapy.

Immunogenicity and antitumor activity of a liposomal MUC1 peptide‐based vaccine

M. Reddish, B. Longenecker, G. Zimmermann, 1998, International journal of cancer.

Effect of acyclovir on the uptake of 131 I‐labelled 1‐(2′fluoro‐2′‐deoxy‐βD‐D‐arabinofuranosyl)‐5‐lodouracil in herpes infected cells

H. Misra, L. Wiebe, J. Samuel, 1987, Journal of medical virology.

Utilization of particulate and immuno-modulating adjuvants for enhancement of immune response against tumors antigenic markers

M. Jafari, M. Tafaghodi, J. Samuel, 2004 .

Airway Neutrophil Recruitment Produced by Mouse Th17 Cells and Induces An IL-17F/A Heterodimer Protein Is

Goldman, L. Fouser, Frann Bennett, 2007 .

Immunoadjuvant activity of the nanoparticles’ surface modified with mannan

A. Lavasanifar, S. Hamdy, A. Haddadi, 2014, Nanotechnology.

Delivery of rapamycin by PLGA nanoparticles enhances its suppressive activity on dendritic cells.

J. Shapiro, A. Lavasanifar, A. Haddadi, 2008, Journal of biomedical materials research. Part A.

Quantitative uptake studies of 131I-labeled (E)-5-(2-iodovinyl)-2'-deoxyuridine in herpes simplex virus-infected cells in vitro

D. Tyrrell, L. Wiebe, J. Samuel, 1984, Antimicrobial Agents and Chemotherapy.

Synthesis of 131I, 125I and 82Br labelled (E)-5-(2-halovinyl)-2'-deoxyuridines.

D. Tyrrell, L. Wiebe, J. Samuel, 1984, The International journal of applied radiation and isotopes.

Analysis of peptide and lipopeptide content in liposomes.

G. Kwon, J. Samuel, M. E. C. Lutsiak, 2002, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant

M. Reddish, B. Longenecker, J. Nabholtz, 2005, Cancer Immunology, Immunotherapy.

Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen-Friedenreich) determinant using a synthetic carbohydrate antigen.

S. Poppema, J. Samuel, R. Koganty, 1992, Journal of immunotherapy : official journal of the Society for Biological Therapy.

Use of a liposome antigen delivery system to alter immune responses in vivo.

D. Wishart, G. Kwon, J. Samuel, 1998, Journal of pharmaceutical sciences.

Activation of Antigen-Specific T Cell-Responses by Mannan-Decorated PLGA Nanoparticles

A. Lavasanifar, A. Shayeganpour, S. Hamdy, 2011, Pharmaceutical Research.

Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.

M. E. Christopher, J. Wong, L. Nagata, 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Pharmaceutical analysis of synthetic lipid A-based vaccine adjuvants in poly (D,L-lactic-co-glycolic acid) nanoparticle formulations.

Vishwanatha Somayaji, S. Hamdy, A. Haddadi, 2007, Journal of pharmaceutical and biomedical analysis.

Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres.

M. Tafaghodi, M. Diwan, J. Samuel, 2002, Journal of controlled release : official journal of the Controlled Release Society.

Dose sparing of CpG oligodeoxynucleotide vaccine adjuvants by nanoparticle delivery.

Praveen Elamanchili, M. Diwan, Min Cao, 2004, Current drug delivery.

The effect of fatty acid substitution on the in vitro release of amphotericin B from micelles composed of poly(ethylene oxide)-block-poly(N-hexyl stearate-L-aspartamide).

G. Kwon, A. Lavasanifar, J. Samuel, 2002, Journal of controlled release : official journal of the Controlled Release Society.

High-performance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin.

D. Brocks, A. Lavasanifar, A. Shayeganpour, 2007, Biomedical chromatography : BMC.

Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery.

John Samuel, Afsaneh Lavasanifar, G. Kwon, 2002, Advanced drug delivery reviews.

The effect of serum albumin on the aggregation state and toxicity of amphotericin B.

G. Kwon, A. Lavasanifar, P. Aramwit, 2000, Journal of pharmaceutical sciences.

Liposomal formulations of synthetic MUC1 peptides: effects of encapsulation versus surface display of peptides on immune responses.

M. Reddish, B. Longenecker, M. Krantz, 1998, Bioconjugate chemistry.

Ovalbumin peptide encapsulated in poly(d,l lactic-co-glycolic acid) microspheres is capable of inducing a T helper type 1 immune response.

G. Kwon, K. D. Newman, J. Samuel, 1998, Journal of controlled release : official journal of the Controlled Release Society.

Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors.

G. Kwon, R. Lai, A. Alshamsan, 2008, International journal of pharmaceutics.

The effect of alkyl core structure on micellar properties of poly(ethylene oxide)-block-poly(L-aspartamide) derivatives.

G. Kwon, A. Lavasanifar, J Samuel, 2001, Colloids and surfaces. B, Biointerfaces.

“Pathogen-Mimicking” Nanoparticles for Vaccine Delivery to Dendritic Cells

S. Hamdy, Praveen Elamanchili, M. Diwan, 2007, Journal of immunotherapy.

In vitro uptake of gelatin nanoparticles by murine dendritic cells and their intracellular localisation.

J. Samuel, C. Coester, P. Nayyar, 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Analysis of human tumor associated Thomsen-Friedenreich antigen.

M. Suresh, B. Longenecker, B. M. Longenecker, 1990, Cancer research.

Delivery of MUC1 mucin peptide by Poly(d,l-lactic-co-glycolic acid) microspheres induces type 1 T helper immune responses.

G. Kwon, K. D. Newman, J. Samuel, 1998, Journal of pharmaceutical sciences.

Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery.

John Samuel, D. Tyrrell, G. Kwon, 2005, Journal of controlled release : official journal of the Controlled Release Society.

Pharmacokinetics and metabolism of E-5-(2-[131I]iodovinyl)-2'-deoxyuridine in dogs

D. Tyrrell, L. Wiebe, J. Samuel, 1986, Antimicrobial Agents and Chemotherapy.

STAT3 silencing in dendritic cells by siRNA polyplexes encapsulated in PLGA nanoparticles for the modulation of anticancer immune response.

A. El-Kadi, H. Uludaǧ, A. Alshamsan, 2010, Molecular pharmaceutics.

Delivery of rapamycin-loaded nanoparticle down regulates ICAM-1 expression and maintains an immunosuppressive profile in human CD34+ progenitor-derived dendritic cells.

A. Haddadi, J. Samuel, Saswati Das, 2008, Journal of biomedical materials research. Part A.

Active targeting of dendritic cells with mannan-decorated PLGA nanoparticles

John Samuel, Afsaneh Lavasanifar, Azita Haddadi, 2011, Journal of drug targeting.

The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine.

A. El-Kadi, H. Uludaǧ, A. Alshamsan, 2010, Biomaterials.

Cytoplasmic delivery of a macromolecular fluorescent probe by poly(d, l-lactic-co-glycolic acid) microspheres.

G. Kwon, G. Miller, K. D. Newman, 2000, Journal of biomedical materials research.

Use of encapsulated single chain antibodies for induction of anti-idiotypic humoral and cellular immune responses.

G. Kwon, D. Luo, J. Samuel, 1998, Journal of pharmaceutical sciences.

Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo.

G. Kwon, K. D. Newman, Praveen Elamanchili, 2002, Journal of biomedical materials research.

STAT3 Knockdown in B16 Melanoma by siRNA Lipopolyplexes Induces Bystander Immune Response In Vitro and In Vivo.

A. El-Kadi, H. Uludaǧ, A. Alshamsan, 2011, Translational oncology.

Biodegradable Nanoparticle Mediated Antigen Delivery to Human Cord Blood Derived Dendritic Cells for Induction of Primary T Cell Responses

Praveen Elamanchili, M. Diwan, J. Samuel, 2003, Journal of drug targeting.

Analysis of Poly(D,L-Lactic-Co-Glycolic Acid) Nanosphere Uptake by Human Dendritic Cells and Macrophages In Vitro

John Samuel, M. E. Christine Lutsiak, Glen S. Kwon, 2002, Pharmaceutical Research.

Induction of anti-idiotypic humoral and cellular immune responses by a murine monoclonal antibody recognizing the ovarian carcinoma antigen CA125 encapsulated in biodegradable microspheres

G. Kwon, Jie Ma, J. Samuel, 1998, Cancer Immunology, Immunotherapy.

Encapsulation of plasmid DNA in biodegradable poly(D, L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery.

G. Kwon, J. Samuel, Deborah R. Robinson, 1999, Journal of controlled release : official journal of the Controlled Release Society.

Biodegradable nanoparticle delivery of a Th2‐biased peptide for induction of Th1 immune responses

John Samuel, G. Kwon, Glen S Kwon, 2006, The Journal of pharmacy and pharmacology.

Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.

G. Kwon, Daqing Wang, Praveen Elamanchili, 2007, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

STAT 3 Knockdown in B 16 Melanoma by siRNA Lipopolyplexes Induces Bystander Immune Response In Vitro and In Vivo 1

A. El-Kadi, A. Alshamsan, A. Lavasanifar, 2011 .

Evaluation of nose-only aerosol inhalation chamber and comparison of experimental results with mathematical simulation of aerosol deposition in mouse lungs.

Venkatareddy Nadithe, W. Finlay, J. Mercer, 2003, Journal of pharmaceutical sciences.

Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles.

A. Alshamsan, T. Satou, S. Hamdy, 2007, Journal of biomedical materials research. Part A.

Immunomodulatory and anticancer effects of intra-tumoral co-delivery of synthetic lipid A adjuvant and STAT3 inhibitor, JSI-124

A. Lavasanifar, S. Hamdy, Zengshuan Ma, 2009, Immunopharmacology and immunotoxicology.

Formulation and delivery of siRNA by oleic acid and stearic acid modified polyethylenimine.

H. Uludaǧ, A. Alshamsan, A. Lavasanifar, 2009, Molecular pharmaceutics.

Synergistic antitumor effects of CpG oligodeoxynucleotide and STAT3 inhibitory agent JSI‐124 in a mouse melanoma tumor model

R. Lai, A. Lavasanifar, S. Hamdy, 2008, Immunology and cell biology.

Nanoparticulate Delivery Systems for Control of Immunity

John Samuel, Manish Diwan, Praveen Elamanchili, 2004, 2004 International Conference on MEMS, NANO and Smart Systems (ICMENS'04).

Self-associating poly(ethylene oxide)-b-poly(alpha-cholesteryl carboxylate-epsilon-caprolactone) block copolymer for the solubilization of STAT-3 inhibitor cucurbitacin I.

John Samuel, Afsaneh Lavasanifar, A. Lavasanifar, 2009, Biomacromolecules.

The in vitro evaluation of nucleoside analogues as probes for use in the noninvasive diagnosis of herpes simplex encephalitis.

D. Tyrrell, H. Misra, L. Wiebe, 1988, Drug design and delivery.

A simple cellular automaton model for influenza A viral infections.

John Samuel, Jack Tuszynski, J. Tuszynski, 2004, Journal of theoretical biology.

Effective drug-antibody targeting using a novel monoclonal antibody against the proliferative compartment of mammalian squamous carcinomas

E. Diener, B. M. Longenecker, J. Samuel, 2005, Cancer Immunology, Immunotherapy.

Development of a sensitive and specific liquid chromatography/mass spectrometry method for the quantification of cucurbitacin I (JSI-124) in rat plasma.

G. Kwon, D. Brocks, A. Lavasanifar, 2006, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

Active targeting of dendritic cells with mannan-decorated PLGA nanoparticles

A. Lavasanifar, S. Hamdy, A. Haddadi, 2011, Journal of drug targeting.

Biocompatible chitosan nanoparticles as an efficient delivery vehicle for Mycobacterium tuberculosis lipids to induce potent cytokines and antibody response through activation of T cells in mice

John Samuel, Afsaneh Lavasanifar, Azita Haddadi, 2014 .

Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity.

A. Alshamsan, A. Lavasanifar, S. Hamdy, 2008, Vaccine.